Articles Published in 2012

Sutro, Celgene to develop next-gen ADCs and bispecific antibodies

Wednesday, December 19, 2012 09:14 AM

Sutro Biopharma, a San Francisco-based biopharmaceutical company, has formed a collaboration with Celgene, a multinational biopharmaceutical company, to design and develop novel antibody drug conjugates (ADCs) and bispecific antibodies for two undisclosed targets and to manufacture a proprietary Celgene antibody.

More... »

Teva signs new $3B syndicated revolving credit facility

Tuesday, December 18, 2012 02:23 PM

Teva Pharmaceutical Industries, a global pharmaceutical company, has entered into a new five-year, $3 billion unsecured revolving credit facility, which replaces its existing $2.5 billion credit facility.

More... »

DIA appoints Lyngvig as new European director

Tuesday, December 18, 2012 01:55 PM

DIA, a neutral, global, professional and member-driven association of nearly 18,000 professionals, has appointed Jytte Lyngvig as director for DIA Europe.

More... »

Zuckerman gives $200M to Columbia University, endows Mind Brain Behavior Institute

Tuesday, December 18, 2012 12:29 PM

Mortimer B. Zuckerman has pledged $200 million to endow a Mind Brain Behavior Institute at Columbia University to support interdisciplinary neuroscience research and discovery by scholars across the university.

More... »

FDA clears IND for first study protocol developed using crowdsourcing

Tuesday, December 18, 2012 12:02 PM

The FDA has cleared the Investigational New Drug Application (IND) for lisinopril to be assessed as an adjunctive therapy for multiple sclerosis (MS), according to Transparency Life Sciences (TLS), a drug development company based on open innovation.

More... »

ZeinCRO expands to 14 CSEE countries total

Tuesday, December 18, 2012 11:35 AM

ZeinCRO, a CRO based in Europe, has reinforced its position in Central- and South- Eastern Europe (CSEE), with the opening of offices in 5 additional countries, extending its reach to 14 countries in total.

More... »

UAB to enroll patients in pilot study using Mytrus’ iPad app

Tuesday, December 18, 2012 11:08 AM

The University of Alabama at Birmingham (UAB) will use an iPad application developed by Mytrus, a clinical technology and services company for medical and pharmaceutical research, in an upcoming pilot study supported by the U.S. Department of Health & Human Services Agency for Healthcare Research and Quality.  

More... »

IMI launches $319M 8th call for proposals

Tuesday, December 18, 2012 10:41 AM

The Innovative Medicines Initiative (IMI), the world’s largest public-private partnership in health, is launching its eighth call for proposals. With a total budget of $319 million ($188 million cash from IMI, plus a $131 million in-kind contribution from participating EFPIA companies), the projects resulting from this call will tackle some of the biggest challenges in health research.

More... »

Takeda sells non-Colcrys URL Pharma to Sun Pharmaceutical

Tuesday, December 18, 2012 10:13 AM

Takeda Pharmaceuticals U.S.A. has entered into a definitive agreement to sell the non-Colcrys (colchicine, USP) URL Pharma generic business to Caraco Pharmaceutical Laboratories, a wholly-owned subsidiary of Sun Pharmaceutical Industries.

More... »

Soligenix acquires novel innate defense regulator clinical program

Tuesday, December 18, 2012 09:44 AM

Soligenix, a Princeton, N.J.-based development stage biopharmaceutical company, has acquired a novel drug technology, known as SGX94, representing a unique approach to modulation of the innate immune system. 

More... »